Following groundbreaking research that established the cardioprotective effects of SGLT2 inhibitors in HF, numerous studies using animal models have highlighted their potential to reduce cardiotoxicity caused by DOX, as seen in Table 1. Here, SLC5A2 is linked to hydrops fetalis.